We are live on ! Find out more
SGK

Steigerwald Gordon & Koch Portfolio holdings

AUM $1.01B
1-Year Est. Return 15.33%
This Fund
S&P 500
This Quarter Est. Return
+13.37%
1 Year Est. Return
+15.33%
3 Year Est. Return
+59.48%
5 Year Est. Return
+77.26%
10 Year Est. Return
+288.1%
AUM
$629M
AUM Growth
+$83M
Cap. Flow
+$16.2M
Cap. Flow %
2.58%
Top 10 Hldgs %
31.69%
Holding
113
New
10
Increased
63
Reduced
25
Closed
1

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.1M
2
ZTS icon
Zoetis
ZTS
+$915K
3
TGT icon
Target
TGT
+$699K
4
T icon
AT&T
T
+$667K
5
DIS icon
Walt Disney
DIS
+$663K

Top Sells

Rank Stock Value
1
TIP icon
iShares TIPS Bond ETF
TIP
+$472K
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$423K
3
DE icon
Deere & Co
DE
+$320K
4
META icon
Meta Platforms (Facebook)
META
+$290K
5
ICF icon
iShares Select U.S. REIT ETF
ICF
+$229K

Sector Composition

Rank Sector Weight
1 Technology 24.32%
2 Healthcare 17.04%
3 Industrials 14.45%
4 Financials 11.77%
5 Consumer Staples 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WEC icon
101
WEC Energy
WEC
$37B
$222K 0.04%
2,370
– –
IEF icon
102
iShares 7-10 Year Treasury Bond ETF
IEF
$47.4B
$218K 0.03%
+2,278
New +$219K
SPYM
103
State Street SPDR Portfolio S&P 500 ETF
SPYM
$160B
$216K 0.03%
4,804
– –
IVW icon
104
iShares S&P 500 Growth ETF
IVW
$71.9B
$215K 0.03%
3,681
– –
PANW icon
105
Palo Alto Networks
PANW
$260B
$209K 0.03%
3,000
– –
MDLZ icon
106
Mondelez International
MDLZ
$80.2B
$207K 0.03%
+3,112
New +$197K
VHT icon
107
Vanguard Health Care ETF
VHT
$18.6B
$207K 0.03%
+833
New +$202K
TMO icon
108
Thermo Fisher Scientific
TMO
$214B
$204K 0.03%
+370
New +$196K
BMY icon
109
Bristol-Myers Squibb
BMY
$130B
$203K 0.03%
+2,824
New +$213K
UNP icon
110
Union Pacific
UNP
$175B
$201K 0.03%
+971
New +$199K
TXN icon
111
Texas Instruments
TXN
$253B
$200K 0.03%
+1,212
New +$202K
GETR.WS
112
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$457 ﹤0.01%
10,000
– –
META icon
113
Meta Platforms (Facebook)
META
$1.51T
– –
-2,135
Closed -$290K
1 2 3 4
5

Similar funds

EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return

Steigerwald Gordon & Koch's Q4 2022 Portfolio in Review

As of Q4 2022, Steigerwald Gordon & Koch held 113 positions worth $629M, up 15% from $546M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Steigerwald Gordon & Koch's Q4 2022 filing shows 10 new, 63 increased, 25 reduced and 1 closed positions. Its largest new stake was Target: 4,457 shares worth $664K. The largest sale was iShares TIPS Bond ETF, an estimated $472K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Steigerwald Gordon & Koch's largest Q4 2022 buy was Target: 4,457 shares worth $664K.
  • Steigerwald Gordon & Koch added most to Apple in Q4 2022, an estimated $2.1M increase.
  • Steigerwald Gordon & Koch's biggest Q4 2022 reduction was iShares TIPS Bond ETF, cutting an estimated $472K.
  • Steigerwald Gordon & Koch fully exited Meta Platforms (Facebook) in Q4 2022, selling an estimated $290K.
  • Steigerwald Gordon & Koch's ten largest holdings make up 32% of its $629M portfolio in Q4 2022.
  • Steigerwald Gordon & Koch opened 10 new positions and closed 1 in Q4 2022.
  • Steigerwald Gordon & Koch's portfolio value rose 15% quarter-over-quarter to $629M.

Based on Steigerwald Gordon & Koch's 13F filing for Q4 2022, filed 17 Jan 2023.